Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;26(3):265-71.
doi: 10.1089/jop.2009.0123.

Vitreal pharmacokinetics of peptide-transporter-targeted prodrugs of ganciclovir in conscious animals

Kumar G Janoria  1 , Sai H S Boddu, Subramanian Natesan, Ashim K Mitra
Affiliations

Vitreal pharmacokinetics of peptide-transporter-targeted prodrugs of ganciclovir in conscious animals

Kumar G Janoria et al. J Ocul Pharmacol Ther. 2010 Jun.

Abstract

Purpose: To delineate the vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV) with conscious rabbit model using ocular microdialysis and to compare with published results from anesthetized model.

Methods: New Zealand albino male rabbit was selected as the animal model. Conscious animal ocular microdialysis technique with permanently implanted probes was employed to delineate the pharmacokinetics of GCV, L-valine-GCV (Val-GCV), and dipeptide monoester GCV prodrugs [val-val and L-glycine-val (Gly-Val)] after intravitreal administration.

Results: This work employs conscious model to evaluate vitreal pharmacokinetic parameters and compares the results with previously published data from anesthetized animal, thereby demonstrating the effect of anesthesia on the vitreal disposition of dipeptide prodrugs of GCV. Results have revealed that area under curve (AUC), clearance, and last measured plasma concentration (C(last)) for all 4 compounds were significantly altered in a conscious animal relative to the anesthetized model, while mean residence time (MRT) was significantly reduced. However, the AUCs of regenerated Val-GCV and GCV from Gly-Val-GCV and Val-Val-GCV were found to be unchanged, suggesting higher ocular metabolism in conscious animals.

Conclusion: This study for the first time delineates the vitreal pharmacokinetics of a GCV prodrug in conscious animals and compares the data with anesthetized animals. Lower vitreal exposure levels were obtained in case of conscious animal model; however, the elimination rates were not influenced by anesthesia.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Vitreous concentration–time profile of ganciclovir (GCV). Mean values are represented (n = 4).
FIG. 2.
FIG. 2.
Vitreous concentration–time profiles of valine-ganciclovir (Val-GCV) and regenerated GCV. Mean values are represented (n = 4).
FIG. 3.
FIG. 3.
Vitreous concentration–time profiles of valine-valine-ganciclovir (Val-Val-GCV), regenerated GCV, and Val-GCV. Mean values are represented (n = 4).
FIG. 4.
FIG. 4.
Vitreous concentration–time profiles of glycine valine-ganciclovir (Gly-Val-GCV), regenerated GCV, and Val-GCV. Mean values are represented (n = 4).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Pepose J.S. Holland G.N. Nestor M.S. Cochran A.J. Foos R.Y. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology. 1985;4:472–484. - PubMed
    1. Bloom J.N. Palestine A.G. The diagnosis of cytomegalovirus retinitis. Ann. Intern. Med. 1988;12:963–969. - PubMed
    1. Cunningham E.T., Jr. Margolis T.P. Ocular manifestations of HIV infection. N. Engl. J. Med. 1998;4:236–244. - PubMed
    1. Arruda R.F. Muccioli C. Belfort R., Jr. [Ophthalmological findings in HIV infected patients in the post-HAART (Highly Active Anti-retroviral Therapy) era, compared to the pre-HAART era] Rev. Assoc. Med. Bras. 2004;2:148–152. - PubMed
    1. Kempen J.H. Jabs D.A. Wilson L.A. Dunn J.P. West S.K. Tonascia J.A. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch. Ophthalmol. 2003;4:466–476. - PubMed

Publication types

LinkOut - more resources